AMENDMENT NO. 1 TO THE STOCK PURCHASE AGREEMENTThe Stock Purchase Agreement • January 19th, 2006 • Xcyte Therapies Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 19th, 2006 Company Industry JurisdictionTHIS AMENDMENT NO. 1 TO THE STOCK PURCHASE AGREEMENT (as amended, supplemented, restated or otherwise modified from time to time, the “Amendment“) is entered into as of January 13, 2006 between Xcyte Therapies, Inc., a Delaware corporation (“Xcyte“) and Cyclacel Group PLC, a public limited company organized under the laws of England and Wales with registered number 5090795 (“Seller”). All capitalized terms not defined in this Amendment shall have the meanings ascribed to them by the Stock Purchase Agreement (as defined below).
AMENDMENT NO. 1 TO THE STOCK PURCHASE AGREEMENTThe Stock Purchase Agreement • January 19th, 2006 • Xcyte Therapies Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 19th, 2006 Company Industry JurisdictionTHIS AMENDMENT NO. 1 TO THE STOCK PURCHASE AGREEMENT (as amended, supplemented, restated or otherwise modified from time to time, the “Amendment“) is entered into as of January 13, 2006 between Xcyte Therapies, Inc., a Delaware corporation (“Xcyte“) and Cyclacel Group PLC, a public limited company organized under the laws of England and Wales with registered number 5090795 (“Seller”). All capitalized terms not defined in this Amendment shall have the meanings ascribed to them by the Stock Purchase Agreement (as defined below).